Global Tyrosine Kinase Inhibitors Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	195 Pages	TechNavio	December, 2024	INF19463173

Best Price Guarantee
Price	from $2,500
Length	195 Pages
Publisher	TechNavio
Published Date	December, 2024
SKU	INF19463173

Tyrosine Kinase Inhibitors Market 2025-2029

The tyrosine kinase inhibitors market is forecasted to grow by USD 21.8 bn during 2024-2029, accelerating at a CAGR of 7.7% during the forecast period. The report on the tyrosine kinase inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high target affinity and specificity of tyrosine kinase inhibitors, rising availability of patient assistance programs, and increasing prevalence of cancer worldwide.

Technavio's tyrosine kinase inhibitors market is segmented as below:

By Product

RTKIs
nRTKIs

By Distribution Channel

Offline
Online

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the strategic alliances among market vendors as one of the prime reasons driving the tyrosine kinase inhibitors market growth during the next few years. Also, expansion of research areas in tyrosine kinase inhibitor therapeutics and increasing launches of biosimilars will lead to sizable demand in the market.

The report on the tyrosine kinase inhibitors market covers the following areas:

Tyrosine Kinase Inhibitors Market sizing
Tyrosine Kinase Inhibitors Market forecast
Tyrosine Kinase Inhibitors Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tyrosine kinase inhibitors market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Danaher Corp., Eisai Co. Ltd., Eli Lilly and Co., Exelixis Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Merck KGaA, Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Rigel Pharmaceuticals Inc., Takeda Pharmaceutical Co. Ltd., and Tokyo Chemical Industry Co. Ltd.. Also, the tyrosine kinase inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Distribution Channel; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ billion); Data Table on Global - Market size and forecast 2024-2029 ($ billion); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Tyrosine Kinase Inhibitors Market 2019 - 2023; Historic Market Size - Data Table on Global Tyrosine Kinase Inhibitors Market 2019 - 2023 ($ billion); 5.2 Product segment analysis 2019 - 2023; Historic Market Size - Product Segment 2019 - 2023 ($ billion); 5.3 Distribution Channel segment analysis 2019 - 2023; Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion); 5.4 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ billion); 5.5 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 The impact of AI in Global Tyrosine Kinase Inhibitors Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2024-2029 (%); Data Table on Product - Market share 2024-2029 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 RTKIs - Market size and forecast 2024-2029; Chart on RTKIs - Market size and forecast 2024-2029 ($ billion); Data Table on RTKIs - Market size and forecast 2024-2029 ($ billion); Chart on RTKIs - Year-over-year growth 2024-2029 (%); Data Table on RTKIs - Year-over-year growth 2024-2029 (%); 8.4 nRTKIs - Market size and forecast 2024-2029; Chart on nRTKIs - Market size and forecast 2024-2029 ($ billion); Data Table on nRTKIs - Market size and forecast 2024-2029 ($ billion); Chart on nRTKIs - Year-over-year growth 2024-2029 (%); Data Table on nRTKIs - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Product; Market opportunity by Product ($ billion); Data Table on Market opportunity by Product ($ billion)
9 Market Segmentation by Distribution Channel: 9.1 Market segments; Chart on Distribution Channel - Market share 2024-2029 (%); Data Table on Distribution Channel - Market share 2024-2029 (%); 9.2 Comparison by Distribution Channel; Chart on Comparison by Distribution Channel; Data Table on Comparison by Distribution Channel; 9.3 Offline - Market size and forecast 2024-2029; Chart on Offline - Market size and forecast 2024-2029 ($ billion); Data Table on Offline - Market size and forecast 2024-2029 ($ billion); Chart on Offline - Year-over-year growth 2024-2029 (%); Data Table on Offline - Year-over-year growth 2024-2029 (%); 9.4 Online - Market size and forecast 2024-2029; Chart on Online - Market size and forecast 2024-2029 ($ billion); Data Table on Online - Market size and forecast 2024-2029 ($ billion); Chart on Online - Year-over-year growth 2024-2029 (%); Data Table on Online - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by Distribution Channel; Market opportunity by Distribution Channel ($ billion); Data Table on Market opportunity by Distribution Channel ($ billion)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape: 11.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 11.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 11.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ billion); Data Table on North America - Market size and forecast 2024-2029 ($ billion); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 11.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ billion); Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 11.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ billion); Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 11.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 11.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 11.8 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ billion); Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 11.9 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ billion); Data Table on UK - Market size and forecast 2024-2029 ($ billion); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 11.10 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ billion); Data Table on China - Market size and forecast 2024-2029 ($ billion); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 11.11 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ billion); Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 11.12 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ billion); Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 11.13 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ billion); Data Table on India - Market size and forecast 2024-2029 ($ billion); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 11.14 South Korea - Market size and forecast 2024-2029; Chart on South Korea - Market size and forecast 2024-2029 ($ billion); Data Table on South Korea - Market size and forecast 2024-2029 ($ billion); Chart on South Korea - Year-over-year growth 2024-2029 (%); Data Table on South Korea - Year-over-year growth 2024-2029 (%); 11.15 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ billion); Data Table on France - Market size and forecast 2024-2029 ($ billion); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 11.16 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ billion); Data Table on Italy - Market size and forecast 2024-2029 ($ billion); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 11.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; SWOT; 14.5 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; SWOT; 14.6 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 14.7 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; SWOT; 14.8 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; SWOT; 14.9 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; SWOT; 14.10 Danaher Corp.; Danaher Corp. - Overview; Danaher Corp. - Business segments; Danaher Corp. - Key news; Danaher Corp. - Key offerings; Danaher Corp. - Segment focus; SWOT; 14.11 Eisai Co. Ltd.; Eisai Co. Ltd. - Overview; Eisai Co. Ltd. - Business segments; Eisai Co. Ltd. - Key offerings; Eisai Co. Ltd. - Segment focus; SWOT; 14.12 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key offerings; SWOT; 14.13 Exelixis Inc.; Exelixis Inc. - Overview; Exelixis Inc. - Product / Service; Exelixis Inc. - Key offerings; SWOT; 14.14 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 14.15 Johnson and Johnson Inc.; Johnson and Johnson Inc. - Overview; Johnson and Johnson Inc. - Business segments; Johnson and Johnson Inc. - Key news; Johnson and Johnson Inc. - Key offerings; Johnson and Johnson Inc. - Segment focus; SWOT; 14.16 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 14.17 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 14.18 Takeda Pharmaceutical Co. Ltd.; Takeda Pharmaceutical Co. Ltd. - Overview; Takeda Pharmaceutical Co. Ltd. - Product / Service; Takeda Pharmaceutical Co. Ltd. - Key news; Takeda Pharmaceutical Co. Ltd. - Key offerings; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits11: Overview on criticality of inputs and factors of differentiation; Exhibits12: Overview on factors of disruption; Exhibits13: Impact of drivers and challenges in 2024 and 2029; Exhibits14: Parent Market; Exhibits15: Data Table on - Parent Market; Exhibits16: Market characteristics analysis; Exhibits17: Value chain analysis; Exhibits18: Offerings of companies included in the market definition; Exhibits19: Market segments; Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ billion); Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ billion); Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Historic Market Size - Data Table on Global Tyrosine Kinase Inhibitors Market 2019 - 2023 ($ billion); Exhibits25: Historic Market Size - Product Segment 2019 - 2023 ($ billion); Exhibits26: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion); Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ billion); Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ billion); Exhibits29: Five forces analysis - Comparison between 2024 and 2029; Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits35: Chart on Market condition - Five forces 2024 and 2029; Exhibits36: Chart on Product - Market share 2024-2029 (%); Exhibits37: Data Table on Product - Market share 2024-2029 (%); Exhibits38: Chart on Comparison by Product; Exhibits39: Data Table on Comparison by Product; Exhibits40: Chart on RTKIs - Market size and forecast 2024-2029 ($ billion); Exhibits41: Data Table on RTKIs - Market size and forecast 2024-2029 ($ billion); Exhibits42: Chart on RTKIs - Year-over-year growth 2024-2029 (%); Exhibits43: Data Table on RTKIs - Year-over-year growth 2024-2029 (%); Exhibits44: Chart on nRTKIs - Market size and forecast 2024-2029 ($ billion); Exhibits45: Data Table on nRTKIs - Market size and forecast 2024-2029 ($ billion); Exhibits46: Chart on nRTKIs - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on nRTKIs - Year-over-year growth 2024-2029 (%); Exhibits48: Market opportunity by Product ($ billion); Exhibits49: Data Table on Market opportunity by Product ($ billion); Exhibits50: Chart on Distribution Channel - Market share 2024-2029 (%); Exhibits51: Data Table on Distribution Channel - Market share 2024-2029 (%); Exhibits52: Chart on Comparison by Distribution Channel; Exhibits53: Data Table on Comparison by Distribution Channel; Exhibits54: Chart on Offline - Market size and forecast 2024-2029 ($ billion); Exhibits55: Data Table on Offline - Market size and forecast 2024-2029 ($ billion); Exhibits56: Chart on Offline - Year-over-year growth 2024-2029 (%); Exhibits57: Data Table on Offline - Year-over-year growth 2024-2029 (%); Exhibits58: Chart on Online - Market size and forecast 2024-2029 ($ billion); Exhibits59: Data Table on Online - Market size and forecast 2024-2029 ($ billion); Exhibits60: Chart on Online - Year-over-year growth 2024-2029 (%); Exhibits61: Data Table on Online - Year-over-year growth 2024-2029 (%); Exhibits62: Market opportunity by Distribution Channel ($ billion); Exhibits63: Data Table on Market opportunity by Distribution Channel ($ billion); Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits65: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits66: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits67: Chart on Geographic comparison; Exhibits68: Data Table on Geographic comparison; Exhibits69: Chart on North America - Market size and forecast 2024-2029 ($ billion); Exhibits70: Data Table on North America - Market size and forecast 2024-2029 ($ billion); Exhibits71: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits72: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits73: Chart on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits74: Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits75: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits76: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits77: Chart on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits78: Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits79: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits80: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits85: Chart on US - Market size and forecast 2024-2029 ($ billion); Exhibits86: Data Table on US - Market size and forecast 2024-2029 ($ billion); Exhibits87: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits88: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits89: Chart on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits90: Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits91: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits92: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits93: Chart on UK - Market size and forecast 2024-2029 ($ billion); Exhibits94: Data Table on UK - Market size and forecast 2024-2029 ($ billion); Exhibits95: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on China - Market size and forecast 2024-2029 ($ billion); Exhibits98: Data Table on China - Market size and forecast 2024-2029 ($ billion); Exhibits99: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits102: Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits103: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on Japan - Market size and forecast 2024-2029 ($ billion); Exhibits106: Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Exhibits107: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on India - Market size and forecast 2024-2029 ($ billion); Exhibits110: Data Table on India - Market size and forecast 2024-2029 ($ billion); Exhibits111: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on South Korea - Market size and forecast 2024-2029 ($ billion); Exhibits114: Data Table on South Korea - Market size and forecast 2024-2029 ($ billion); Exhibits115: Chart on South Korea - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on South Korea - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on France - Market size and forecast 2024-2029 ($ billion); Exhibits118: Data Table on France - Market size and forecast 2024-2029 ($ billion); Exhibits119: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on Italy - Market size and forecast 2024-2029 ($ billion); Exhibits122: Data Table on Italy - Market size and forecast 2024-2029 ($ billion); Exhibits123: Chart on Italy - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on Italy - Year-over-year growth 2024-2029 (%); Exhibits125: Market opportunity By Geographical Landscape ($ billion); Exhibits126: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits127: Impact of drivers and challenges in 2024 and 2029; Exhibits128: Overview on criticality of inputs and factors of differentiation; Exhibits129: Overview on factors of disruption; Exhibits130: Impact of key risks on business; Exhibits131: Companies covered; Exhibits132: Company ranking index; Exhibits133: Matrix on companies position and classification; Exhibits134: AbbVie Inc. - Overview; Exhibits135: AbbVie Inc. - Product / Service; Exhibits136: AbbVie Inc. - Key news; Exhibits137: AbbVie Inc. - Key offerings; Exhibits138: SWOT; Exhibits139: Amgen Inc. - Overview; Exhibits140: Amgen Inc. - Product / Service; Exhibits141: Amgen Inc. - Key news; Exhibits142: Amgen Inc. - Key offerings; Exhibits143: SWOT; Exhibits144: AstraZeneca Plc - Overview; Exhibits145: AstraZeneca Plc - Product / Service; Exhibits146: AstraZeneca Plc - Key news; Exhibits147: AstraZeneca Plc - Key offerings; Exhibits148: SWOT; Exhibits149: Bayer AG - Overview; Exhibits150: Bayer AG - Business segments; Exhibits151: Bayer AG - Key news; Exhibits152: Bayer AG - Key offerings; Exhibits153: Bayer AG - Segment focus; Exhibits154: SWOT; Exhibits155: Boehringer Ingelheim International GmbH - Overview; Exhibits156: Boehringer Ingelheim International GmbH - Product / Service; Exhibits157: Boehringer Ingelheim International GmbH - Key news; Exhibits158: Boehringer Ingelheim International GmbH - Key offerings; Exhibits159: SWOT; Exhibits160: Bristol Myers Squibb Co. - Overview; Exhibits161: Bristol Myers Squibb Co. - Product / Service; Exhibits162: Bristol Myers Squibb Co. - Key news; Exhibits163: Bristol Myers Squibb Co. - Key offerings; Exhibits164: SWOT; Exhibits165: Danaher Corp. - Overview; Exhibits166: Danaher Corp. - Business segments; Exhibits167: Danaher Corp. - Key news; Exhibits168: Danaher Corp. - Key offerings; Exhibits169: Danaher Corp. - Segment focus; Exhibits170: SWOT; Exhibits171: Eisai Co. Ltd. - Overview; Exhibits172: Eisai Co. Ltd. - Business segments; Exhibits173: Eisai Co. Ltd. - Key offerings; Exhibits174: Eisai Co. Ltd. - Segment focus; Exhibits175: SWOT; Exhibits176: Eli Lilly and Co. - Overview; Exhibits177: Eli Lilly and Co. - Product / Service; Exhibits178: Eli Lilly and Co. - Key offerings; Exhibits179: SWOT; Exhibits180: Exelixis Inc. - Overview; Exhibits181: Exelixis Inc. - Product / Service; Exhibits182: Exelixis Inc. - Key offerings; Exhibits183: SWOT; Exhibits184: F. Hoffmann La Roche Ltd. - Overview; Exhibits185: F. Hoffmann La Roche Ltd. - Business segments; Exhibits186: F. Hoffmann La Roche Ltd. - Key news; Exhibits187: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits188: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits189: SWOT; Exhibits190: Johnson and Johnson Inc. - Overview; Exhibits191: Johnson and Johnson Inc. - Business segments; Exhibits192: Johnson and Johnson Inc. - Key news; Exhibits193: Johnson and Johnson Inc. - Key offerings; Exhibits194: Johnson and Johnson Inc. - Segment focus; Exhibits195: SWOT; Exhibits196: Novartis AG - Overview; Exhibits197: Novartis AG - Business segments; Exhibits198: Novartis AG - Key news; Exhibits199: Novartis AG - Key offerings; Exhibits200: Novartis AG - Segment focus; Exhibits201: SWOT; Exhibits202: Pfizer Inc. - Overview; Exhibits203: Pfizer Inc. - Product / Service; Exhibits204: Pfizer Inc. - Key news; Exhibits205: Pfizer Inc. - Key offerings; Exhibits206: SWOT; Exhibits207: Takeda Pharmaceutical Co. Ltd. - Overview; Exhibits208: Takeda Pharmaceutical Co. Ltd. - Product / Service; Exhibits209: Takeda Pharmaceutical Co. Ltd. - Key news; Exhibits210: Takeda Pharmaceutical Co. Ltd. - Key offerings; Exhibits211: SWOT; Exhibits212: Inclusions checklist; Exhibits213: Exclusions checklist; Exhibits214: Currency conversion rates for US$; Exhibits215: Research methodology; Exhibits216: Information sources; Exhibits217: Data validation; Exhibits218: Validation techniques employed for market sizing; Exhibits219: Data synthesis; Exhibits220: 360 degree market analysis; Exhibits221: List of abbreviations